Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal N6-methyladenosine (m6A) antibody. Carrier free. Suitable for FRET, Dot and reacts with Nucleic Acid samples.
View Alternative Names
N6-methyladenosine, m6A
- Dot
Supplier Data
Dot Blot - Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] - BSA and Azide free (AB314477)
This data was developed using ab314476, the same antibody clone in a different buffer formulation. Dot blot analysis of N6-methyladenosine (m6A) using ab314476 at 1 : 5000 (0.106 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 20,000 dilution. Lane 1 : Hela (human cervical adenocarcinoma epithelial cell) total RNA Lane 2 : Hela (human cervical adenocarcinoma epithelial cell) mRNA Exposure time : 200s Blocking and diluting buffer and concentration : 5% NFDM/TBST
- FRET
Supplier Data
FRET - Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] - BSA and Azide free (AB314477)
This data was developed using ab314476, the same antibody clone in a different buffer formulation. A FRET-based assay was performed using 25 nm of each biotinylated oligo and ab314476 at a concentration range of 0.001-4.000 ug/ml. The Secondary antibody used was SA_D2 binding to antigen, GAR_tb binding to antibody at 1 : 100 dilution. Antigen : m6A RNA oligo, m6Am RNA oligo, Am RNA oligo, m6, 6A RNA oligo, m1A RNA oligo, m8A RNA oligo, m1G RNA oligo, m2G RNA oligo, A RNA oligo. Antigen concentration : 100 nmol/ml
- Dot
Supplier Data
Dot Blot - Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] - BSA and Azide free (AB314477)
This data was developed using ab314476, the same antibody clone in a different buffer formulation. Dot blot analysis of N6-methyladenosine (m6A) using ab314476 at 1 : 5000 (0.106 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 20,000 dilution. Lane 1 : A-oligo Lane 2 : m6A-oligo Lane 3 : m6Am-oligo Lane 4 : Am-oligo Lane 5 : m6, 6A-oligo Lane 6 : m1A-oligo Lane 7 : m8A-oligo Lane 8 : m1G-oligo Lane 9 : m2G-oligo Exposure time : 5s Blocking and diluting buffer and concentration : 5% NFDM/TBST
Related conjugates and formulations (1)
-
Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2]
Reactivity data
Product details
ab314477 is the carrier-free version of ab314476.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
M6A methylation affects mRNA processing stability translation and decay. It integrates into large multi-protein complexes where it influences gene expression outcomes by affecting the RNA's interaction with the cellular machinery. This methylation modification acts as a regulatory signal that influences essential processes such as cell differentiation and circadian rhythms. Elucidating the biological functions of m6A involves studying how it affects RNA fate and its downstream gene regulatory networks.
Pathways
M6A modification is central to the mRNA metabolic pathway and the PI3K-Akt signaling pathway. It interacts with various proteins such as METTL3 an m6A methyltransferase which is vital for mediating m6A modification. It also interacts with YTH domain-containing proteins that recognize m6A marks influencing transcript dynamics and gene expression. The interplay of m6A with proteins in these pathways underlines its role in fine-tuning cellular processes and responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com